ATE377586T1 - Tripeptidylpeptidaseinhibitoren - Google Patents

Tripeptidylpeptidaseinhibitoren

Info

Publication number
ATE377586T1
ATE377586T1 AT98966427T AT98966427T ATE377586T1 AT E377586 T1 ATE377586 T1 AT E377586T1 AT 98966427 T AT98966427 T AT 98966427T AT 98966427 T AT98966427 T AT 98966427T AT E377586 T1 ATE377586 T1 AT E377586T1
Authority
AT
Austria
Prior art keywords
tripeptidylpeptidase
inhibitors
compound
concerns
peptidase
Prior art date
Application number
AT98966427T
Other languages
English (en)
Inventor
Jean-Charles Schwartz
Christiane Rose
Froylan Vargas
Charon Ganellin
Lihua Zhao
Sanjeeda Samad
Yongjun Chen
Original Assignee
Inst Nat Sante Rech Med
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Bioprojet Soc Civ filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE377586T1 publication Critical patent/ATE377586T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
AT98966427T 1997-12-23 1998-12-23 Tripeptidylpeptidaseinhibitoren ATE377586T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97403148 1997-12-23

Publications (1)

Publication Number Publication Date
ATE377586T1 true ATE377586T1 (de) 2007-11-15

Family

ID=8229935

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98966427T ATE377586T1 (de) 1997-12-23 1998-12-23 Tripeptidylpeptidaseinhibitoren

Country Status (11)

Country Link
US (1) US6335360B1 (de)
EP (1) EP1042288B1 (de)
JP (1) JP3943332B2 (de)
AT (1) ATE377586T1 (de)
CA (1) CA2315703C (de)
CY (1) CY1107039T1 (de)
DE (1) DE69838686T2 (de)
DK (1) DK1042288T3 (de)
ES (1) ES2297905T3 (de)
PT (1) PT1042288E (de)
WO (1) WO1999033801A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03003868A (es) 2000-10-30 2003-07-28 Janssen Pharmaceutica Nv Inhibidores de tripeptidil peptidasa.
US6864742B2 (en) * 2001-06-08 2005-03-08 Northrop Grumman Corporation Application of the doherty amplifier as a predistortion circuit for linearizing microwave amplifiers
US20040097422A1 (en) * 2002-06-14 2004-05-20 Karl Munger Methods of use for tripeptidyl peptidase II inhibitors as anticancer agents
JP2009523157A (ja) * 2006-01-13 2009-06-18 オンコレー アーベー 虚血および神経変性の処置のための化合物
US20100240591A1 (en) * 2007-06-25 2010-09-23 Oncoreg Ab Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
CN110256326B (zh) * 2019-07-16 2022-05-13 辽宁中医药大学 马齿苋中一种二氢吲哚羧酸类生物碱及其提取分离方法与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206757D0 (en) * 1992-03-27 1992-05-13 Ferring Bv Novel peptide receptor ligands
CA2118985A1 (en) * 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
FR2723739B1 (fr) * 1994-08-19 1997-02-14 Sanofi Sa Derives de glycinamide, procedes pour leur preparation et medicaments les contenant.
FR2733995B1 (fr) * 1995-05-09 1997-07-25 Inst Nat Sante Rech Med Inhibiteurs de l'inactivation de neuropeptides endogenes notamment la cholecystokinine, leurs procedes de preparation leur utilisation comme medicaments et procede de criblage de medicaments

Also Published As

Publication number Publication date
CA2315703C (en) 2008-02-05
US6335360B1 (en) 2002-01-01
JP2002535240A (ja) 2002-10-22
ES2297905T3 (es) 2008-05-01
EP1042288A1 (de) 2000-10-11
PT1042288E (pt) 2008-03-11
WO1999033801A1 (en) 1999-07-08
EP1042288B1 (de) 2007-11-07
CA2315703A1 (en) 1999-07-08
DK1042288T3 (da) 2008-01-28
DE69838686D1 (de) 2007-12-20
CY1107039T1 (el) 2012-09-26
JP3943332B2 (ja) 2007-07-11
DE69838686T2 (de) 2008-08-28

Similar Documents

Publication Publication Date Title
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
BR9805544C1 (pt) Uso de um composto.
SE9703693D0 (sv) Novel combination
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
AU2001271686A1 (en) Compounds to treat alzheimer's disease
PT1193270E (pt) Pirrolobenzodiazepinas
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
DE69816280D1 (de) Inhibitoren des impdh-enzyms
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BR9815469A (pt) Inibidores de protease
EA200201175A1 (ru) Применение ингибиторов il-18 для лечения и/или предотвращения атеросклероза
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
DE60329326D1 (de) Tace inhibitoren
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
ATE287403T1 (de) 6-phenylbenzonaphthyidine
BG100248A (bg) Инхибитори на скваленсинтетаза
DE69930844D1 (de) Inhibitoren von mycobakterien
SE0302361D0 (sv) Inhibering av upptagning av monoamin
GB9626472D0 (en) New use of comt inhibitors
WO2001024784A3 (en) New use
MXPA05010800A (es) Acidos hidroxamicos utiles en el tratamiento de trastornos hiperproliferativos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1042288

Country of ref document: EP

REN Ceased due to non-payment of the annual fee